ORCID iD and Google Scholar linked to profiles in the BOPA website

Dear Members,

Great news! you can now link your ORCID iD and Google Scholar to your profile in the BOPA website. BOPA are proud to support research within the oncology pharmacy community and we would like to make it easier for members to showcase their work as well as link with others who also conduct research.

If you do not have an account yet but have published – then please set up an account with ORCID iD and Google Scholar and then link to your BOPA profile.

If you already have accounts with ORCID iD and Google Scholar then it is easy to link by going into ‘My Dashboard’ click ‘edit profile’ and it is just under the photo section!

Netty Cracknell

BOPA Website Manager

Latest News

By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article
By BOPA Executive Committee on 24th August 2026

BOPA 2026 Executive Committee Election – Have you cast your vote for your candidates?

Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…

Read article